绝经后骨质疏松症应用骨疏康治疗的临床效果研究.docVIP

绝经后骨质疏松症应用骨疏康治疗的临床效果研究 　　[摘要] 目的 探讨应用中药骨舒康治疗绝经后骨质疏松患者的临床疗效。方法 将该院78例绝经后骨质疏松患者随机分为两组，观察组和对照组各39例。对照组采用常规治疗方法，观察组患者采用中药骨舒康治疗，观察比较两组患者治疗前后髋部骨密度、血清ALP含量。结果 治疗前两组患者髋部骨密度、血清ALP比较差异无统计学意义（P0.05）；治疗两个疗程后，观察组与对照组的骨密度分别为（0.76±0.07）g/cm、（0.62±0.06）g/cm，较对照组高，治疗后观察组患者血清ALP含量为（58.2±23.4）U/L，明显高于对照组的（74.3±27.3）U/L。组间比较差异有统计学意义（P0.05）。结论 中药骨舒康在治疗绝经后骨质疏松症时，能显著增加患者的骨密度和血清ALP含量，有效改善临床症状，可在临床治疗中推广应用。 　　[关键词] 绝经后骨质疏松症；骨疏康；临床疗效 　　[中图分类号] R4 [文献标识码] A [文章编号] 1674-0742（2015）05（c）-0156-02 　　[Abstract] Objective Observe the application Chinese medicine bone acbel clinical curative effect for the treatment of patients with postmenopausal osteoporosis. Methods From 78 patients with postmenopausal osteoporosis were randomly divided into two groups： observation group and control group 39 cases each. The control group using conventional treatment method， the observation group were treated by Chinese medicine bone acbel treatment.Two groups of patients were compared before and after treatment of hip bone mineral density， serum ALP content.Results Two groups before treatment in patients with hip bone mineral density and serum ALP were no significant difference（P0.05）； After two courses of treatment， observation group and control group of bone mineral density， respectively （0.76 ±0.07） g/cm squared， （0.62±0.06） g/cm squared， higher than control group， the observation group of patients after treatment serum ALP content is （58.2±23.4） U/L， significantly higher than that of control group （74.3±27.3） U/L. More significant difference between groups（P0.05）. Conclusion Shukang medicine bone in osteoporosis therapy after menopause can significantly increase bone density in patients with serum ALP content， improve clinical symptoms， could be applied in the clinical treatment. 　　[Key words] Postmenopausal osteoporosis； Gushukang； Clinical efficacy 　　骨质疏松症是老年人群中常见疾病，尤其是绝经后骨质疏松症最为多见。绝经后妇女长时期刺激素缺乏，骨吸收超过骨形成，引起骨量减少，使骨结构遭到破坏，导致骨强度下降，诱发骨折危险，影响绝经后妇女的正常生活[1]。该研究在2014年1月―2015年1月期间以该院收治的78例绝经后骨质疏松妇女为主要研究对象，分析